⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6243137 | 0.82 | — | — | |
| SCHEMBL10585381 | 0.78 | — | — | |
| SCHEMBL5328465 | 0.78 | HTT (0.40) | — | |
| SCHEMBL9059251 | 0.78 | — | — | |
| SCHEMBL2905803 | 0.78 | — | — | |
| SCHEMBL6239079 | 0.78 | HTT (0.40) | — | |
| SCHEMBL15135062 | 0.78 | HTT (0.37) | — | |
| SCHEMBL12078160 | 0.76 | — | — | |
| SCHEMBL1104285 | 0.76 | HTT (0.36) | — | |
| SCHEMBL13446920 | 0.76 | HTT (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0140865-A1 | Enhanced 2-hydroxy-4-methylthiobutanoic acid composition and method of preparation | Monsanto Company (US) | 1985-05-08 | — | — | EP | claimed |
| JP-7041462-A | — | — | None | — | — | JP | disclosed |
| JP-8157447-A | — | — | None | — | — | JP | disclosed |
| US-9427001-B2 | Enhanced bioavailable iodine molecules | ZINPRO CORPORATION (US) | 2016-08-30 | — | — | US | disclosed |
| US-9392810-B2 | Enhanced bioavailable iodine molecules | ZINPRO CORPORATION (US) | 2016-07-19 | — | — | US | disclosed |
| US-9149057-B2 | Enhanced bioavailable iodine molecules | ZINPRO CORPORATION (US) | 2015-10-06 | — | — | US | disclosed |
| US-9144246-B2 | Enhanced bioavailable iodine molecules | ZINPRO CORPORATION (US) | 2015-09-29 | — | — | US | disclosed |
| EP-2680710-A2 | ENHANCED BIOAVAILABLE IODINE MOLECULES | Zinpro Corporation (US) | 2014-01-08 | — | — | EP | disclosed |
| US-20130267724-A1 | ENHANCED BIOAVAILABLE IODINE MOLECULES | ZINPRO CORPORATION (US) | 2013-10-10 | — | — | US | disclosed |
| US-20130230619-A1 | ENHANCED BIOAVAILABLE IODINE MOLECULES | ZINPRO CORPORATION (US) | 2013-09-05 | — | — | US | disclosed |
| US-20130225847-A1 | ENHANCED BIOAVAILABLE IODINE MOLECULES | ZINPRO CORPORATION (US) | 2013-08-29 | — | — | US | disclosed |
| WO-2012118688-A2 | ENHANCED BIOAVAILABLE IODINE MOLECULES | ZINPRO CORPORATION (US) | 2012-09-07 | — | — | WO | disclosed |
| US-20120225161-A1 | ENHANCED BIOAVAILABLE IODINE MOLECULES | ZINPRO CORPORATION (US) | 2012-09-06 | — | — | US | disclosed |
| JP-H08157447-A | PRODUCTION OF 2-HYDROXYMETHYLMERCAPTOBUTYRIC ACID | DAICEL CHEM IND LTD | 1996-06-18 | — | — | JP | disclosed |
| JP-H0741462-A | PRODUCTION OF 2-HYDROXYMETHYLMERCAPTOBUTYRIC ACID | DAICEL CHEM IND LTD | 1995-02-10 | — | — | JP | disclosed |